An Open Label Study of Multiple Doses of Cannabidiol in the Prevention of Acute Graft-Versus-Host Disease (GVHD)

NCT03840512 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Prevention aGVHD

Interventions

DRUG: CBD

Sponsor

Kalytera Therapeutics Israel, Ltd.